Antibiotics could be key in dandruff treatment
Washington — A report in the Journal of Medicinal Chemistry may offer researchers a new avenue to treating one of the leading causes of dandruff, the unsightly shedding of excess skin cells off the scalp.
Researchers studied the fungus Malassezia globosa, which causes irritation on the scalp, leading to dandruff. According to Medical News Today, researchers identified an essential enzyme in the fungus, which could become the target for new anti-dandruff medications. The report also shows that sulfonamides, antibacterial agents, were more effective at neutralizing the fungus than ketoconazole, a widely used antifungal medicine found in many dandruff treatments.
The study’s authors believe that targeting the isolated enzyme with antibiotics along with antifungals may help lead to a new wave of effective treatments for the condition, which affects as much as half of the world’s population.
Go back to the Dermatology Times eNews newsletter.
MORE ARTICLES IN THIS ISSUE
Drugmaker Halscion announced that its product Celotres has received European CE mark approval. Celotres is a hydrogel scaffold used to improve wound healing and scarring.
Researchers in Sweden have successfully described the function and structure of the topmost layer of skin at the molecular level, creating new possibilities for large-scale drug delivery via the skin and also opening the door for greater understanding of skin diseases.
The American Society for Laser Medicine and Surgery named George J. Hruza, M.D., president at the organization’s annual conference in April.